State Street Corp Re Shape Lifesciences Inc. Transaction History

State Street Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.86 - $1.86 $946 - $2,046	1,100 Added 5.61%	20,700 $24,000
Q3 2021 Nov 15, 2021	SELL	$2.67 - $5.09 $241,365 - $460,130	-90,399 Reduced 82.18%	19,600 $56,000
Q2 2021 Aug 16, 2021	BUY	$2.02 - $7.64 $222,197 - $840,392	109,999 New	109,999 $550,000

Ticker RSLS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,559,400
Market Cap $4.74M
Description
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.